Top News
Home >> Marketplace Archives >> Enzo validated antibodies for IHC

Enzo validated antibodies for IHC

Print Friendly, PDF & Email

 

June 2018—Enzo Life Sciences introduced three clinically relevant antibodies for immunohistochemistry detection. The p16INK4A monoclonal antibody is an antibody specific for a cyclin-dependent kinase inhibitor that plays an important regulatory role in the cell cycle. The HER2/Neu monoclonal antibody is an antibody specific for a proto-oncogenic transmembrane receptor tyrosine kinase that is clinically indicated in a number of carcinomas. The Ki-67 monoclonal antibody is a nuclear, non-histone protein that is expressed only during active phases of the cell cycle (G1, S, G2, and M) but not in the resting phases (G0 and G1 early phase).

Enzo Life Sciences, 800-942-0430

x

Check Also

Enzo offers nanopolymer ISH, IHC reagents

Aug. 18, 2016—Enzo Life Sciences has introduced a new line of in situ hybridization and...

X